Blog
FDA's New Biosimilars Guidance
Blog
From the FDA – New Biosimilars Guidance
Blog
Fed. Cir.: Antitrust Issues Can Arise From Hatch-Waxman Litigation
Blog
Ignorance is Bliss – for Teva
Blog
USPTO TRIPs over Myriad-Mayo guidance
Blog
FDA Accepts First Biosimilar Application for Review
Blog
Experian Marketing Solutions, Inc. v. RPost Communications Ltd. – PTAB finds electronic messaging a "technological invention" outside ambit of Covered Business Method review
Blog
Digitech Image Technologies, LLC v. Electronics For Imaging, Inc. — Data structures per se not patentable
Blog
Q. Todd Dickinson Resigns as Executive Director of AIPLA
Blog
Myriad Guidance Comments
Blog
Abbvie V. Janssen Biotech –Written Description Requirement Road Map
Blog